Thrivent Financial for Lutherans’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-368,499
Closed -$11.8M 2521
2021
Q4
$11.8M Buy
368,499
+2,826
+0.8% +$103K 0.02% 628
2021
Q3
$13.2M Buy
365,673
+33,644
+10% +$1.32M 0.03% 593
2021
Q2
$14.6M Buy
332,029
+94,113
+40% +$4.1M 0.03% 568
2021
Q1
$10.9M Buy
237,916
+69,765
+41% +$4M 0.02% 631
2020
Q4
$11.6M Buy
+168,151
New +$8.23M 0.03% 600

Other funds holding LUNG

Thrivent Financial for Lutherans's LUNG Position: Q1 2022 in Review

Thrivent Financial for Lutherans sold out of Pulmonx (LUNG) in Q1 2022, closing a stake of 368,499 shares — an estimated $11.8M sold.

Thrivent Financial for Lutherans first reported a position in LUNG in Q4 2020 and held it in 5 quarters. The position peaked at $14.6M in Q2 2021. 109 funds tracked by Wall St. Rank hold LUNG as of Q1 2022.

  • Thrivent Financial for Lutherans reported no remaining Pulmonx position as of Q1 2022 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 368,499 Pulmonx shares in Q1 2022, an estimated $11.8M.
  • Thrivent Financial for Lutherans first reported a position in Pulmonx in Q4 2020 and held it in 5 quarters.
  • Thrivent Financial for Lutherans's Pulmonx position peaked at $14.6M in Q2 2021.
  • 109 funds tracked by Wall St. Rank held Pulmonx as of Q1 2022.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2022, filed 13 May 2022.